X hits on this document

33 views

0 shares

0 downloads

0 comments

6 / 12

4.118-X§4.118—Schedule of ratings–skin      4.118-X

least 5 percent, but less than 20 percent, of exposed areas affected,

or; intermittent systemic therapy such as corticosteroids or other

immunosuppressive drugs required for a total duration of less than

six weeks during the past 12-month period10

Less than 5 percent of the entire body or exposed areas affected, and;

no more than topical therapy required during the past 12-month

period0

Or rate as disfigurement of the head, face, or neck (DC 7800) or scars

(DC’s 7801, 7802, 7803, 7804, or 7805), depending upon the predominant

disability.

7817  Exfoliative dermatitis (erythroderma):

Generalized involvement of the skin, plus systemic manifestations

(such as fever, weight loss, and hypoproteinemia), and; constant or

near-constant systemic therapy such as therapeutic doses of

corticosteroids, immunosuppressive retinoids, PUVA (psoralen

with long-wave ultraviolet-A light) or UVB (ultraviolet-B light)

treatments, or electron beam therapy required during the past

12-month period100

Generalized involvement of the skin without systemic manifestations,

and; constant or near-constant systemic therapy such as therapeutic

doses of corticosteroids, immunosuppressive retinoids, PUVA (psoralen

with long-wave ultraviolet-A light) or UVB (ultraviolet-B light)

treatments, or electron beam therapy required during the past

12-month period60

Any extent of involvement of the skin, and; systemic therapy such

as therapeutic doses of corticosteroids, immunosuppressive retinoids,

PUVA (psoralen with long-wave ultraviolet-A light) or UVB

(ultraviolet-B light) treatments, or electron beam therapy required

for a total duration of six weeks or more, but not constantly, during

the past 12-month period30

Any extent of involvement of the skin, and; systemic therapy such

as therapeutic doses of corticosteroids, immunosuppressive retinoids,

PUVA (psoralen with long-wave ultraviolet-A light) or UVB

(ultraviolet-B light) treatments, or electron beam therapy required

for a total duration of less than six weeks during the past 12-month

period10

Any extent of involvement of the skin, and; no more than topical

therapy required during the past 12-month period0

7818  Malignant skin neoplasms (other than malignant melanoma):

Rate as disfigurement of the head, face, or neck (DC 7800), scars (DC’s 7801, 7802,

7803, 7804, or7805), or impairment of function.

(No. 51  2/5/12)

Document info
Document views33
Page views33
Page last viewedSun Dec 04 07:00:38 UTC 2016
Pages12
Paragraphs368
Words3750

Comments